Table of Contents :
• Stock Rating & Target Price
• Investment Thesis
• Fundamental Models Used
• Company Description
• Corporate Timeline
• Key Metrics (KPI ) and Recently Reported Earnings Review
• Business Highlights, Strategic Announcements & Outlook
• Quarter-over-Quarter (Q-o-Q) and Year-over-Year (Y-o-Y) Growth Analysis
• Key Catalysts Driving Growth
• Historical Financial Statement Analysis & CAGR Trends
• Quarterly Key Financial Ratios and Performance Metrics
• Annual Financial Performance Analysis: Horizontal and Vertical Financial Analysis, Trends
• Financial Forecasts
• Annual Forecasts: Income Statement
• Annual Forecasts: Cash Flow Statements
• Net Debt Levels
• A Closer Look at DCF: Our Assumptions and Methodology
• Terminal Value Calculation
• Target Price Analysis
• Valuation Multiples
• Supplementary Valuation Analysis: Multiples Approach
• Scenario/Sensitivity Analysis – Base Case , Bull Case ,Bear Case
• Holistic Peer Review & Trading Comps: Financial Data, Operational Metrics, and Valuation Multiples
• Implied Price Per Share
• Ownership Activity/ Insider Trades
• Ownership Summary
• An analysis of ESG Risk Rating
• Key Professionals
• Key Board Members
• Key Risks Considerations
• Analyst Ratings
• Analyst Industry Views
• Disclosures
Leidos Holdings Inc (LDOS) Delivers on Margin and Mission—But Can NorthStar Execution Turn Strategic Positioning Into Shareholder Payoff?
Leidos posted a strong Q1 FY25, with 7% YoY organic growth to $4.25B in revenue and a record 14.2% adjusted EBITDA margin, up 190bps, reflecting superior execution across all segments—Defense, Health & Civil, and Commercial & International. Notably, C&I delivered a second straight quarter of double-digit growth, and EPS grew 30% YoY, demonstrating leverage from favorable program mix and disciplined delivery. The NorthStar 2030 framework is driving strategic capital allocation, aligning with federal imperatives in space, cyber, energy, and digital modernization, while the company’s $226B pipeline and $25B in submitted proposals provide strong backlog visibility. Despite a soft 0.5x book-to-bill, management maintained full-year guidance, signaling confidence in back-half award activity and procurement ramp. A $500M accelerated share repurchase and a tuck-in cyber acquisition further validate high-conviction capital deployment. The setup into FY26 includes expanding addressable programs such as FAA airspace modernization, Golden Dome defense layers, and scaled federal health platforms. With 2.5x leverage and ~$840M cash, Leidos retains buyback and M&A flexibility. Execution cadence is accelerating, but ultimate investor reward hinges on how well NorthStar priorities translate into sustainable margin lift and durable earnings growth. Will NorthStar’s strategic alignment and operational momentum be sufficient to drive meaningful, lasting value for shareholders?
